These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 19088948

  • 1. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J.
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the heart rate-lowering action of ivabradine, a selective I(f) current inhibitor.
    Borer JS, Le Heuzey JY.
    Am J Ther; 2008 Oct; 15(5):461-73. PubMed ID: 18806523
    [Abstract] [Full Text] [Related]

  • 3. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK, Gray D, Purcell H.
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [Abstract] [Full Text] [Related]

  • 4. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Feb; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 5. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D.
    J Physiol; 2006 Apr 15; 572(Pt 2):335-46. PubMed ID: 16484306
    [Abstract] [Full Text] [Related]

  • 6. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 7. Drug insight: If inhibitors as specific heart-rate-reducing agents.
    Borer JS.
    Nat Clin Pract Cardiovasc Med; 2004 Dec 27; 1(2):103-9. PubMed ID: 16265314
    [Abstract] [Full Text] [Related]

  • 8. I(f) inhibition in cardiovascular diseases.
    Thollon C, Vilaine JP.
    Adv Pharmacol; 2010 Dec 27; 59():53-92. PubMed ID: 20933199
    [Abstract] [Full Text] [Related]

  • 9. Ivabradine: beyond heart rate control.
    Riccioni G, Vitulano N, D'Orazio N.
    Adv Ther; 2009 Jan 27; 26(1):12-24. PubMed ID: 19165437
    [Abstract] [Full Text] [Related]

  • 10. Heart rate reduction via selective 'funny' channel blockers.
    Bucchi A, Barbuti A, Baruscotti M, DiFrancesco D.
    Curr Opin Pharmacol; 2007 Apr 27; 7(2):208-13. PubMed ID: 17267284
    [Abstract] [Full Text] [Related]

  • 11. Focus on ivabradine: a new heart rate-controlling drug.
    Riccioni G.
    Expert Rev Cardiovasc Ther; 2009 Feb 27; 7(2):107-13. PubMed ID: 19210206
    [Abstract] [Full Text] [Related]

  • 12. The role of the funny current in pacemaker activity.
    DiFrancesco D.
    Circ Res; 2010 Feb 19; 106(3):434-46. PubMed ID: 20167941
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS, Tardif JC.
    Am J Cardiol; 2010 Jan 01; 105(1):29-35. PubMed ID: 20102886
    [Abstract] [Full Text] [Related]

  • 14. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S, Timmis AD.
    Int J Clin Pract; 2006 Feb 01; 60(2):222-8. PubMed ID: 16451297
    [Abstract] [Full Text] [Related]

  • 15. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D, Borer JS.
    Drugs; 2007 Feb 01; 67 Suppl 2():15-24. PubMed ID: 17999560
    [Abstract] [Full Text] [Related]

  • 16. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E, Bonadei I, D'Aloia A, Del Magro F, Piovanelli B, Bontempi L, Curnis A, Dei Cas L.
    Minerva Med; 2011 Oct 01; 102(5):373-9. PubMed ID: 22193347
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM.
    Am J Cardiovasc Drugs; 2012 Dec 01; 12(6):415-26. PubMed ID: 23181944
    [Abstract] [Full Text] [Related]

  • 18. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
    Köster R, Kaehler J, Meinertz T, REDUCTION Study Group.
    Am Heart J; 2009 Oct 01; 158(4):e51-7. PubMed ID: 19781403
    [Abstract] [Full Text] [Related]

  • 19. Ivabradine: from molecular basis to clinical effectiveness.
    Riccioni G.
    Adv Ther; 2010 Mar 01; 27(3):160-7. PubMed ID: 20419486
    [Abstract] [Full Text] [Related]

  • 20. Effect of HCN channel inhibition on retinal morphology and function in normal and dystrophic rodents.
    Della Santina L, Bouly M, Asta A, Demontis GC, Cervetto L, Gargini C.
    Invest Ophthalmol Vis Sci; 2010 Feb 01; 51(2):1016-23. PubMed ID: 19741244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.